Arcus Biosciences, Inc.: cashflow_investing
| Value | {"amount": -460000000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-09-30 |
| Status | current |
| Entity | Arcus Biosciences, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:38:25.694721+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9718d4b1-9ac2-4e40-b3e2-5604841a5f71
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001724521-23-000021 · Open the official SEC filing →Retrieved: 2026-08-19T17:38:25.694721+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001724521/cashflow-investing/2022-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9718d4b1-9ac2-4e40-b3e2-5604841a5f71
History
- supersedes {"amount": -459811000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} (evidence 0000950170-22-021241)